MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Executive Director, HIV+Hepatitis Policy Institute, Washington, D.C.
Carl Schmid has been a national policy and advocacy leader in the HIV community for over 20 years. He spent 16 years with The AIDS Institute, serving as its Deputy Executive Director. In December 2019, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
Mr. Schmid leads advocacy efforts to ensure domestic HIV and hepatitis programs are based on sound public policy and fully funded. He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of beneficiaries, including prescription medications.
In December 2018, he was appointed Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA) and serves as a consumer representative to the National Association of Insurance Commissioners.
He is a cancer survivor and living with chronic hepatitis B.
Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.
HIV+Hep Policy Institute
Executive Director, Policy
Gilead Sciences, Inc.
Foster City, CA
JUSTIN C. SMITH MS, MPH
Director, Campaign to End AIDS
Positive Impact Health Centers
Head of U.S. Government Affairs and Policy
Organon and Co.
Director of External Affairs
Oakland Park, FL
Director of Federal Legislative Advocacy
National Alliance on Mental Illness
Senior Vice President
American Cancer Society
Cancer Action Network
STEVEN R. YOUNG
HIV/AIDS Bureau, HRSA, HHS
Funders for HIV+Hepatitis Policy Institute
HIV+Hep appreciates the support of numerous funders, and recognizes those below that are our corporate members and sponsors:
Facebook posts by @HIV+Hep
Tweets by @HIV+Hep
From @bloomberglaw, @HIVHep’s Carl Schmid on health plans & #ACA requirements to offer #PrEP w/o cost-sharing: “We want everyone to know it’s free. [If] it doesn’t say ‘zero cost-sharing,’ people may not know it. So we want to make it easy as possible”: https://t.co/KqhwlLpOCL.
@HIVHep’s Carl Schmid praises the House-proposed FY22 funding increases for HIV programs but says the proposed + $5 million for @cdchep programs will not be nearly enough to achieve the president’s goal of eliminating #hepatitis by 2030: https://t.co/W7cVrIVmhZ. https://t.co/vPSueoXhlJ
@HIVHep’s Carl Schmid lauded the federal govt issuing guidance that “associated services with #PrEP, such as provider visits & #HIV, #hepatitis, & STD testing along with other laboratory tests must be covered with no #patient cost-sharing”: https://t.co/9r4RVzmlvw. https://t.co/FNifYUgGAq
Today, we, @HIVHep, and over 60 of the nation's leading HIV organizations demanded that @CDCgov reverse its decision to prohibit CDC prevention funds from paying for PrEP provider visits and lab tests 🧵 1/n https://t.co/kb9kHaAN1D